The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia.

Paraneoplastic opsoclonus myoclonus ataxia (POMA) is a neurologic disorder thought to be mediated by an autoimmune attack against onconeural disease antigens that are expressed by gynecologic or lung tumors and by neurons. One POMA disease antigen, termed Nova-1, has been identified as a neuron-specific KH-type RNA-binding protein. Nova-1 expression is restricted to specific regions of the central nervous system, primarily the hindbrain and ventral spinal cord, which correlate with the predominantly motor symptoms in POMA. However, POMA antisera recognize antigens that are widely expressed in both caudal and rostral regions of the central nervous system, and some patients develop cognitive symptoms. We have used POMA antisera to clone a cDNA encoding a second POMA disease antigen termed Nova-2. Nova-2 is closely related to Nova-1, and is expressed at high levels in neurons during development and in adulthood, and at lower levels in the adult lung. In the postnatal mouse brain, Nova-2 is expressed in a pattern that is largely reciprocal with Nova-1, including high levels of Nova-2 expression in the neocortex and hippocampus. Functional characterization of Nova-2 in RNA selection and nitrocellulose filter-binding assays reveals that Nova-2 binds RNA with high affinity and with sequence specificity that differs from Nova-1. Our results demonstrate that the immune response in POMA targets a family of highly related sequence-specific neuronal RNA-binding proteins. The expression pattern of the Nova-2 protein is likely to underlie the development of cognitive deficits in some POMA patients.

[1]  R. Darnell,et al.  Mouse chromosomal locations of nine genes encoding homologs of human paraneoplastic neurologic disorder antigens. , 1997, Genomics.

[2]  G. Dreyfuss,et al.  The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein , 1997, The EMBO journal.

[3]  R. Darnell,et al.  The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo , 1997, Molecular and cellular biology.

[4]  M. Hentze,et al.  mRNA Silencing in Erythroid Differentiation: hnRNP K and hnRNP E1 Regulate 15-Lipoxygenase Translation from the 3′ End , 1997, Cell.

[5]  J. Darnell,et al.  A Post-Transcriptional Regulatory Mechanism Restricts Expression of the Paraneoplastic Cerebellar Degeneration Antigen cdr2 to Immune Privileged Tissues , 1997, The Journal of Neuroscience.

[6]  B. Henderson.  Iron regulatory proteins 1 and 2 , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[7]  M. Hentze,et al.  Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Darnell.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Anne Wright,et al.  Cloning and Characterization of HuR, a Ubiquitously Expressed Elav-like Protein (*) , 1996, The Journal of Biological Chemistry.

[10]  RJ Buckanovich,et al.  The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  Robert B Darnell,et al.  β-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein , 1995, Cell.

[12]  S. Liebhaber,et al.  Identification of two KH domain proteins in the alpha‐globin mRNP stability complex. , 1995, The EMBO journal.

[13]  P. Good.  A conserved family of elav-like genes in vertebrates. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Rosenblum,et al.  Immunological and pathological study of anti‐Ri–associated encephalopathy , 1994, Annals of neurology.

[15]  N. Janjić,et al.  High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Darnell,et al.  Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system , 1993, Neuron.

[17]  J. Keene,et al.  Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. , 1993, Molecular and cellular biology.

[18]  P. Detwiler,et al.  The effect of recoverin-like calcium-Binding proteins on the photoresponse of retinal rods , 1993, Neuron.

[19]  R. Darnell,et al.  The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons , 1993, Neuroscience Letters.

[20]  L. Kline,et al.  Antineuronal (anti‐Ri) antibodies in a patient with steroid‐responsive opsoclonus‐myoclonus , 1993, Neurology.

[21]  M. Pranzatelli.  The neurobiology of the opsoclonus-myoclonus syndrome. , 1992, Clinical neuropharmacology.

[22]  M. Rosenblum,et al.  Anti‐Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients , 1992, Medicine.

[23]  J. Henson,et al.  HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal , 1991, Cell.

[24]  J. Posner,et al.  Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  J. Posner,et al.  Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Palczewski,et al.  A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy , 1991, The Journal of cell biology.

[27]  M. Rosenblum,et al.  Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer , 1991, Annals of neurology.

[28]  M. Kris,et al.  Detection of the anti‐Hu antibody in the serum of patients with small cell lung cancer—A quantitative western blot analysis , 1990, Annals of neurology.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[30]  R. Laskey,et al.  Nuclear targeting sequences--a consensus? , 1991, Trends in biochemical sciences.

[31]  Mental Disease. Meeting,et al.  Immunologic mechanisms in neurologic and psychiatric disease , 1990 .

[32]  Immunologic mechanisms in neurologic and psychiatric diseases. , 1990, Research publications - Association for Research in Nervous and Mental Disease.